Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 2
2004 5
2005 1
2006 4
2007 7
2008 8
2009 4
2010 8
2011 13
2012 11
2013 12
2014 20
2015 13
2016 14
2017 23
2018 29
2019 34
2020 45
2021 37
2022 32
2023 40
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

327 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Itch treatments.
Steinhoff M, Kwatra S, Misery L. Steinhoff M, et al. Among authors: misery l. Front Med (Lausanne). 2024 Feb 16;11:1373702. doi: 10.3389/fmed.2024.1373702. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38468751 Free PMC article. No abstract available.
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.
Tedbirt B, Maho-Vaillant M, Houivet E, Mignard C, Golinski ML, Calbo S, Prost-Squarcioni C, Labeille B, Picard-Dahan C, Chaby G, Richard MA, Tancrede-Bohin E, Duvert-Lehembre S, Delaporte E, Bernard P, Caux F, Alexandre M, Musette P, Ingen-Housz-Oro S, Vabres P, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bédane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Joly P, Hébert V; French Reference Center for Autoimmune Blistering Diseases MALIBUL. Tedbirt B, et al. Among authors: misery l. JAMA Dermatol. 2024 Mar 1;160(3):290-296. doi: 10.1001/jamadermatol.2023.5679. JAMA Dermatol. 2024. PMID: 38265821 Clinical Trial.
A large language model artificial intelligence for patient queries in atopic dermatitis.
Sulejmani P, Negris O, Aoki V, Chu CY, Eichenfield L, Misery L, Mosca A, Orfali RL, Aroman MS, Stalder JF, Trzeciak M, Wollenberg A, Lio P. Sulejmani P, et al. Among authors: misery l. J Eur Acad Dermatol Venereol. 2024 Jan 3. doi: 10.1111/jdv.19737. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38168874 No abstract available.
Classification of psychodermatological disorders: Proposal of a new international classification.
Ferreira BR, Vulink N, Mostaghimi L, Jafferany M, Balieva F, Gieler U, Poot F, Reich A, Romanov D, Szepietowski JC, Tomas-Aragones L, Campos R, Tausk F, Zipser M, Bewley A, Misery L. Ferreira BR, et al. Among authors: misery l. J Eur Acad Dermatol Venereol. 2024 Apr;38(4):645-656. doi: 10.1111/jdv.19731. Epub 2023 Dec 12. J Eur Acad Dermatol Venereol. 2024. PMID: 38084889
Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.
Thyssen JP, Bewley A, Ständer S, Castro C, Misery L, Kim BS, Biswas P, Chan G, Myers DE, Watkins M, Alderfer J, Güler E, Silverberg JI. Thyssen JP, et al. Among authors: misery l. Dermatology. 2024;240(2):243-253. doi: 10.1159/000535285. Epub 2023 Dec 11. Dermatology. 2024. PMID: 38081155 Free PMC article. Clinical Trial.
Baricitinib treatment rapidly improves the four signs of atopic dermatitis assessed by Eczema Area and Severity Index (EASI) clinical subscores.
Wollenberg A, Simon D, Kulthanan K, Figueras-Nart I, Misery L, Tangsirisap N, Spina L, Lu N, Grond S, Eyerich K. Wollenberg A, et al. Among authors: misery l. J Eur Acad Dermatol Venereol. 2024 Apr;38(4):695-702. doi: 10.1111/jdv.19669. Epub 2023 Dec 2. J Eur Acad Dermatol Venereol. 2024. PMID: 38041556 Free article. Clinical Trial.
327 results